Alpharma Inc.

Dr. Aigner has more than 20 years of experience in the global healthcare industry. He is currently the EVP, Corporate and Business Development for Alpharma, Inc. (NYSE: ALO), a leading global specialty pharmaceutical company. Before joining Alpharma, Dr. Aigner was co-founder and Executive Vice President of Business Development for Reliant Pharmaceuticals, Inc., a pharmaceutical company that specializes in the development, commercialization and marketing of prescription therapeutic products. During his tenure with Reliant, Dr. Aigner led the company through multiple product acquisitions and significant in-licensing transactions and was responsible for building the company's cardiovascular portfolio through strong partnerships with leading U.S. and European companies. Prior to Reliant, Dr. Aigner was a consultant with leading healthcare consulting firm The Wilkerson Group, where he focused on development of corporate strategies, assessment of new products, and evaluation of potential partnering candidates.

Peter Tombros has served as a Board Director since 1998 and in January 2008 was appointed Chairman. Previously, he served as Lead Director since May 2006. Since 2005, Mr. Tombros has served as Professor and executive in residence in the Eberly College of Science B.S./M.B.A. Program at Pennsylvania State University. Formerly, he was Chairman and Chief Executive Officer of VivoQuest, a private biopharmaceutical company. From 1994 until June 2001, Mr. Tombros served as President and Chief Executive Officer of Enzon Pharmaceuticals, Inc., a publicly held biopharmaceutical company. Prior to joining Enzon, Mr. Tombros spent 25 years with Pfizer Inc., a global healthcare company in a variety of senior management positions including Vice President of Marketing, Senior Vice President and General Manager of the Roerig Pharmaceuticals Division, Executive Vice President of Pfizer Pharmaceuticals Division, Director of Pfizer Pharmaceuticals Division, Vice President of Corporate Strategic Planning, and Vice President, Corporate Officer, Pfizer Inc. Mr. Tombros is Chairman of PharmaNet Development Group, Inc. and is a Board Director at Cambrex and Protalex, all publicly held life science companies. Peter Tombros earned B.S. and M.S. degrees from Pennsylvania State University and an M.B.A. degree from the University of Pennsylvania Wharton Graduate School of Business.